Factors that predict the probability of a successful clinical outcome after induction of oocyte maturation with a gonadotropin-releasing hormone agonist
Authors:
- Claudio BenadivaCBClaudio Benadiva
- Lawrence EngmannLELawrence Engmann
- 31 July 2011
- journal article
- research article
- Published by Elsevier in Fertility and Sterility
- Vol. 96 (1) , 63-68
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Identification of the High-Risk Patient for Ovarian Hyperstimulation SyndromeSeminars in Reproductive Medicine, 2010
- Gonadotropin-Releasing Hormone Agonist Trigger: The Way to Eliminate Ovarian Hyperstimulation Syndrome—A 20-Year ExperienceSeminars in Reproductive Medicine, 2010
- Gonadotropin-releasing hormone agonist to induce final oocyte maturation prevents the development of ovarian hyperstimulation syndrome in high-risk patients and leads to improved clinical outcomes compared with coastingFertility and Sterility, 2010
- 1,500 IU human chorionic gonadotropin administered at oocyte retrieval rescues the luteal phase when gonadotropin-releasing hormone agonist is used for ovulation induction: a prospective, randomized, controlled studyFertility and Sterility, 2010
- Ovulation triggering with GnRH agonist vs. hCG in the same egg donor population undergoing donor oocyte cycles with GnRH antagonist: a prospective randomized cross-over trialJournal of Assisted Reproduction and Genetics, 2009
- Triggering with HCG or GnRH agonist in GnRH antagonist treated oocyte donation cycles: a randomised clinical trialGynecological Endocrinology, 2009
- Gonadotropin-releasing hormone agonist combined with a reduced dose of human chorionic gonadotropin for final oocyte maturation in fresh autologous cycles of in vitro fertilizationFertility and Sterility, 2008
- The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: a prospective randomized controlled studyFertility and Sterility, 2008
- Triggering of final oocyte maturation with gonadotropin-releasing hormone agonist or human chorionic gonadotropin. Live birth after frozen-thawed embryo replacement cyclesFertility and Sterility, 2007
- Triggering ovulation with gonadotropin-releasing hormone agonists does not compromise embryo implantation ratesFertility and Sterility, 2006